[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520705":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":164,"collaborators":10,"id":166,"slug":167,"hasResults":168,"nctId":169,"briefTitle":170,"officialTitle":170,"acronym":10,"eligibilityCriteria":171,"healthyVolunteers":168,"sex":172,"minAge":173,"maxAge":10,"enrollmentInfo":174,"targetDuration":10,"studyType":177,"phases":10,"briefSummary":178,"conditions":179,"keywords":10,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":192},{"fullName":5,"class":6},"Bausch & Lomb Incorporated","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"IC-8 Apthera intraocular lens (IOL) Group",null,"Patients previously implanted with the IC-8 Apthera intraocular lens (IOL) and who have developed posterior capsular opacification (PCO) which requires treatment with Nd:YAG laser capsulotomy.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Jennifer Laskowski","CONTACT","8183699137","jennifer.laskowski@bausch.com",[19,33,46,56,65,75,85,95,105,115,125,134,144,154],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":10},"Trinity Research Group, LLC","RECRUITING","Dothan","Alabama","36301","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-85.39049,31.22323,{"lat":31,"lon":30},{"facility":34,"status":21,"city":35,"state":36,"zip":37,"country":25,"countryCode":26,"cosmosGeoPoint":38,"geoPoint":42,"contacts":43},"Feinerman Vision Center","Newport Beach","California","92663",{"type":28,"coordinates":39},[40,41],-117.92895,33.61891,{"lat":41,"lon":40},[44],{"name":45,"role":15,"phone":10,"phoneExt":10,"email":10},"OD",{"facility":47,"status":21,"city":48,"state":49,"zip":50,"country":25,"countryCode":26,"cosmosGeoPoint":51,"geoPoint":55,"contacts":10},"Argus Research Center","Cape Coral","Florida","33909",{"type":28,"coordinates":52},[53,54],-81.94953,26.56285,{"lat":54,"lon":53},{"facility":57,"status":21,"city":58,"state":49,"zip":59,"country":25,"countryCode":26,"cosmosGeoPoint":60,"geoPoint":64,"contacts":10},"Stephenson Eye Associates","Venice","34285",{"type":28,"coordinates":61},[62,63],-82.45426,27.09978,{"lat":63,"lon":62},{"facility":66,"status":21,"city":67,"state":68,"zip":69,"country":25,"countryCode":26,"cosmosGeoPoint":70,"geoPoint":74,"contacts":10},"Virdi Eye Clinic and Laser Vision Center","Rock Island","Illinois","61201",{"type":28,"coordinates":71},[72,73],-90.57875,41.50948,{"lat":73,"lon":72},{"facility":76,"status":21,"city":77,"state":78,"zip":79,"country":25,"countryCode":26,"cosmosGeoPoint":80,"geoPoint":84,"contacts":10},"Price Vision Group","Indianapolis","Indiana","46260",{"type":28,"coordinates":81},[82,83],-86.15804,39.76838,{"lat":83,"lon":82},{"facility":86,"status":21,"city":87,"state":88,"zip":89,"country":25,"countryCode":26,"cosmosGeoPoint":90,"geoPoint":94,"contacts":10},"Grene Vision Group","Wichita","Kansas","67206",{"type":28,"coordinates":91},[92,93],-97.33754,37.69224,{"lat":93,"lon":92},{"facility":96,"status":21,"city":97,"state":98,"zip":99,"country":25,"countryCode":26,"cosmosGeoPoint":100,"geoPoint":104,"contacts":10},"Oakland Eye","Birmingham","Michigan","48009",{"type":28,"coordinates":101},[102,103],-83.21132,42.5467,{"lat":103,"lon":102},{"facility":106,"status":21,"city":107,"state":108,"zip":109,"country":25,"countryCode":26,"cosmosGeoPoint":110,"geoPoint":114,"contacts":10},"Vance Thompson Vision - Omaha","Omaha","Nebraska","68137",{"type":28,"coordinates":111},[112,113],-95.94043,41.25626,{"lat":113,"lon":112},{"facility":116,"status":21,"city":117,"state":118,"zip":119,"country":25,"countryCode":26,"cosmosGeoPoint":120,"geoPoint":124,"contacts":10},"Eye Associates of New Jersey","Dover","New Jersey","07801",{"type":28,"coordinates":121},[122,123],-74.5621,40.88399,{"lat":123,"lon":122},{"facility":126,"status":21,"city":127,"state":118,"zip":128,"country":25,"countryCode":26,"cosmosGeoPoint":129,"geoPoint":133,"contacts":10},"Northern New Jersey Eye Institute","South Orange","07079",{"type":28,"coordinates":130},[131,132],-74.26126,40.74899,{"lat":132,"lon":131},{"facility":135,"status":21,"city":136,"state":137,"zip":138,"country":25,"countryCode":26,"cosmosGeoPoint":139,"geoPoint":143,"contacts":10},"Ophthalmic Partners, PC","Bala-Cynwyd","Pennsylvania","19004",{"type":28,"coordinates":140},[141,142],-75.23407,40.00761,{"lat":142,"lon":141},{"facility":145,"status":21,"city":146,"state":147,"zip":148,"country":25,"countryCode":26,"cosmosGeoPoint":149,"geoPoint":153,"contacts":10},"Berkeley Eye Center","Sugar Land","Texas","77478",{"type":28,"coordinates":150},[151,152],-95.63495,29.61968,{"lat":152,"lon":151},{"facility":155,"status":21,"city":156,"state":157,"zip":158,"country":25,"countryCode":26,"cosmosGeoPoint":159,"geoPoint":163,"contacts":10},"Utah Eye Centers","Bountiful","Utah","84010",{"type":28,"coordinates":160},[161,162],-111.88077,40.88939,{"lat":162,"lon":161},{"type":165,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100520705","ic-8-apthera-iol-new-enrollment-post-approval-study-100520705",false,"NCT06060041","IC-8 Apthera IOL New Enrollment Post Approval Study","Inclusion Criteria:\n\n* 22 years of age or older, any race and any gender;\n* Posterior capsule opacification (PCO) requiring treatment in the IC-8 Apthera IOL eye\n* Able to comprehend and have signed a statement of informed consent;\n* Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits;\n* Clear intraocular media in both eyes;\n* Preoperative corneal astigmatism ≤1.5 D in the IC-8 Apthera IOL eye prior to IC-8 Apthera implantation;\n* Prior IC-8 Apthera IOL implantation in one eye and a monofocal\u002Fmonofocal toric IOL in the other eye in accordance with the directions for use (DFU) for each IOL.\n\nExclusion Criteria:\n\n* Pharmacologically dilated pupil size less than 7.0 mm in the IC-8 Apthera IOL eye;\n* Irregular astigmatism in either eye;\n* History of retinal disease;\n* Active or recurrent anterior segment pathology;\n* Presence of ocular abnormalities;\n* Diagnosis of dry eye in which patients are unable to maintain eye comfort or adequate vision even with dry eye treatment;\n* Previous corneal or intraocular surgery, except cataract surgery;\n* History of ocular trauma or ocular conditions expected to require retinal laser treatment or other surgical intervention;\n* Acute, chronic or uncontrolled systemic disease that would, in the opinion of the investigator, confound the outcomes of the study;\n* Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with hormonal fluctuation that could lead to refractive changes and dry eye;\n* Concurrent participation or participation in any clinical trial up to 30 days prior to the first visit in the study.\n* Subjects who plan to be traveling, relocating or otherwise unavailable to attend any of the visits","ALL","22 Years",{"count":175,"type":176},435,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.",[180,181,182],"Cataract","Presbyopia","Posterior Capsule Opacification","2026-01-09",{"date":185,"type":186},"2026-01-12","ACTUAL",{"date":188,"type":186},"2023-09-08",{"date":190,"type":176},"2027-09-30",{"name":5,"class":6},14]